Reshma Singh

This inventor holds 15 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: University of Pennsylvania, Novartis Ag, Advaxis, Inc.. Active years: 2010-2025.

USPTO Granted Patents = 15 (Patent Applications = 4)

% Patents Active = 86.7

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 212(Granted Patents)

Location History:

Philadelphia, PA (US) (2010)
Brookline, MA (US) (2016 - 2018)
Princeton, NJ (US) (2018)
Cambridge, MA (US) (2017 - 2022)

Company Filing History:

14 out of 2,645

University of Pennsylvania

Dana-Farber-Cancer Institute Inc.

University of Georgia Research Foundation Inc

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12338287 - Treatment of cancer using a CD33 chimeric antigen receptor (2025-06-24),

2. 12214037 - Treatment of cancer using humanized anti-BCMA chimeric antigen receptor (2025-02-04),

3. 12186278 - Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy (2025-01-07),

4. 11413340 - Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy (2022-08-16),

5. 11084880 - Anti-BCMA chimeric antigen receptor (2021-08-10),

6. 10851166 - Treatment of cancer using a CD33 chimeric antigen receptor (2020-12-01),

7. 10568947 - Treatment of cancer using a CLL-1 chimeric antigen receptor (2020-02-25),

8. 10174095 - Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor (2019-01-08),

9. 10064898 - Listeria-based adjuvants (2018-09-04),

10. 10058599 - [object Object] (2018-08-28),

11. 9777061 - Treatment of cancer using a CD33 chimeric antigen receptor (2017-10-03),

12. 9463227 - Listeria-based adjuvants (2016-10-11),

13. 7820180 - [object Object] (2010-10-26),

14. 7794729 - Methods and compositions for immunotherapy of cancer (2010-09-14),

15. 7662396 - Compositions and methods for enhancing the immunogenicity of antigens (2010-02-16),

Title: Reshma Singh: Pioneering Inventor from Cambridge

Introduction: Reshma Singh is a trailblazing inventor based in Cambridge, MA, known for her innovative contributions to various fields.

Latest Patents: Reshma Singh holds several patents in the areas of biotechnology, renewable energy, and artificial intelligence, showcasing her diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Reshma has led groundbreaking projects that have revolutionized industries and improved people's lives.

Collaborations: Throughout her career, Reshma has collaborated with top research institutions, leading companies, and brilliant minds from around the world, fostering a culture of innovation and excellence.

Conclusion: Reshma Singh's dedication to pushing the boundaries of technology and her commitment to creating a better future through her inventions make her a true inspiration in the world of innovation.